Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
780.00    -53.00 (-6.36%)
Bid:
780.00
Ask:
783.50
Spread: 3.50 (0.449%)
Market Cap: £898.36m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

6 Sep 2016 07:00

RNS Number : 0050J
Kainos Group plc
06 September 2016
 

 

ANNOUNCEMENT

6 September 2016

 

Kainos Group plc

("Kainos" or "the Group")

Trading Update

 

- Group maintains guidance for current year -

 

Kainos Group plc (KNOS), a leading UK-based provider of IT, consulting and software solutions, today issues a trading update for the period from 1 April 2016 to 31 August 2016.

 

In the Digital Services division, the Group is experiencing good growth in the public sector. Demand from central and regional government clients continues to strengthen, with notable new contract wins at the National Offender Management Service and the Home Office.

 

Demand for WorkSmart services is strong in the UK and mainland Europe, where the Group has added a number of new enterprise clients, including Tullett Prebon Group Limited. Take-up of the Group's SaaS-based automated testing product, Smart, is solid and the Group continues to invest in both product development and sales and marketing for Smart.

 

The Evolve division continues to make progress with its Integrated Care SaaS platform and has signed a five-year subscription agreement with Hygieia to use Evolve to power its insulin therapy navigation application which aims to help diabetics systematically manage their changing insulin requirements. In the UK, the Evolve for iPad™ offering, which allows clinicians to access electronic patient records on the move, is now in live operation at the South East Coast Ambulance Service. Market conditions in the NHS remain challenging, with limited additional funding to drive demand.

 

Although the outcome of the UK's referendum on Europe ('Brexit') brings with it some uncertainties, the Group continues to see immediate opportunities for growth.

 

Kainos has a robust balance sheet with strong reserves, no debt and strong cash generation, as well as a growing level of recurring revenue. The Group expects results for the full year to be in line with market expectations.

 

 

 

 

-ENDS-

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Dominic Emery/Sebastian Lawrence

Patrick Robb/Matt Lewis

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon/Chris Lane

 

About Kainos

Kainos is a UK-based provider of IT services, consulting and software solutions. It specialises across multiple sectors in the development of digital technology solutions, including software design and agile software development. The Group's Evolve Electronic Medical Records (EMR) product provides a market-leading comprehensive suite of digital services to healthcare providers such as hospitals and community care organisations. Kainos has also developed an automated testing product, Smart, to complement its Workday implementation services.

 

Kainos Group plc (KNOS) is listed on the main market of the London Stock Exchange. At 31 March 2016, it had almost 800 staff working in eight offices in the USA, UK, Ireland, Poland and the Netherlands.

 

For further information please visit the company website: https://www.kainos.com/

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLAMFTMBBMBFF
Date   Source Headline
3rd Sep 20207:00 amRNSKainos Trading Update
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20204:27 pmRNSBoard Committee Membership
25th Aug 20204:46 pmRNSHolding(s) in Company
19th Aug 202010:10 amRNSNotice of AGM
5th Aug 20201:13 pmRNSDirector/PDMR Shareholding
31st Jul 202011:29 amRNSTotal Voting Rights
31st Jul 20208:39 amRNSAnnual Report 2020
27th Jul 20207:00 amRNSTrading Update and Special Dividend
3rd Jul 20201:56 pmRNSDirector/PDMR Shareholding
1st Jul 202012:20 pmRNSTotal Voting Rights
30th Jun 20205:10 pmRNSCorrection: Director/PDMR Shareholding
30th Jun 20201:59 pmRNSDirector/PDMR Shareholding
9th Jun 202011:39 amRNSDirector Declaration
9th Jun 20208:59 amRNSDirector/PDMR Shareholding
1st Jun 202011:51 amRNSTotal Voting Rights
28th May 20205:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSPreliminary results for year ended 31 March 2020
1st May 20209:19 amRNSTotal Voting Rights
23rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
23rd Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
14th Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 20201:09 pmRNSTotal Voting Rights
2nd Mar 20207:00 amRNSKainos acquires IntuitiveTEK LLC
31st Jan 202011:28 amRNSTotal Voting Rights
6th Jan 20209:41 amRNSTotal Voting Rights
19th Dec 20195:46 pmRNSHolding(s) in Company
9th Dec 20192:37 pmRNSCORRECTION: Director/PDMR Shareholding
6th Dec 20193:29 pmRNSHolding(s) in Company
6th Dec 20193:29 pmRNSDirector/PDMR Shareholding
5th Dec 201912:02 pmRNSPrice Monitoring Extension
3rd Dec 20193:42 pmRNSDirector/PDMR Shareholding
29th Nov 20194:00 pmRNSHolding(s) in Company
29th Nov 20193:54 pmRNSDirector/PDMR Shareholding
29th Nov 201911:00 amRNSTotal Voting Rights
28th Nov 201910:42 amRNSAppointment of Non-Executive Director
20th Nov 201912:07 pmRNSSecond Price Monitoring Extn
20th Nov 201912:02 pmRNSPrice Monitoring Extension
11th Nov 20197:01 amRNSKainos Acquires Formulate and Implexa
11th Nov 20197:00 amRNSInterim Results
1st Nov 201911:15 amRNSTotal Voting Rights
30th Sep 20193:14 pmRNSTotal Voting Rights
26th Sep 20191:15 pmRNSChairman Appointment & Committee Membership Change
26th Sep 201912:00 pmRNSResults of Annual General Meeting
5th Sep 20195:31 pmRNSHolding(s) in Company
4th Sep 20197:00 amRNSTrading Update
3rd Sep 20193:44 pmRNSHolding(s) in Company
2nd Sep 201910:50 amRNSTotal Voting Rights
21st Aug 20191:40 pmRNSNotice of Annual General Meeting 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.